Green Thumb Industries Inc. (GTBIF) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Green Thumb Industries Inc. (GTBIF) Healthcare & Pipeline Overview

Green Thumb Industries Inc. (GTBIF) is a vertically integrated cannabis company that manufactures, distributes, and retails a portfolio of branded cannabis products in the U.S. adult-use and medical markets. With a focus on branded products and retail expansion, GTBIF aims to capitalize on the growing cannabis market.

What Is the Investment Thesis for GTBIF?

Green Thumb Industries presents a notable research candidate within the expanding cannabis market. With a market capitalization of $1.64B and a P/E ratio of 13.58, GTBIF demonstrates strong financial performance, supported by a gross margin of 47.5% and a profit margin of 9.8%. Growth catalysts include ongoing cannabis legalization efforts across various states and the expansion of GTBIF's retail footprint. The company's focus on branded products and vertically integrated operations positions it well to capitalize on increasing consumer demand. Potential risks include regulatory uncertainties and competition from other cannabis operators. GTBIF's beta of 0.90 suggests lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

GTBIF Key Highlights

Market Cap: $1.64B indicates substantial investor confidence and company size within the cannabis industry.

• P/E Ratio: 13.58 suggests the company's stock is reasonably valued compared to its earnings.
• Profit Margin: 9.8% demonstrates the company's ability to generate profit from its revenue.
• Gross Margin: 47.5% reflects efficient production and pricing strategies.
• 77 Retail Stores (as of April 11, 2022): Shows the company's established retail presence and direct-to-consumer sales channel.

Who Are GTBIF's Competitors?

GTBIF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are GTBIF's Key Strengths?

Vertically integrated operations.

• Strong brand portfolio.
• Extensive retail network.
• Experienced management team.

What Are GTBIF's Weaknesses?

High operating expenses.

• Limited geographic presence compared to larger competitors.
• Dependence on regulatory approvals.
• OTC market listing.

What Could Drive GTBIF Stock Higher?

GTBIF catalyst: Potential federal cannabis legalization in the United States could significantly expand the market for Green Thumb Industries.

• Expansion of retail footprint through new store openings and acquisitions.
• Product innovation and the launch of new cannabis products.
• Increasing consumer acceptance of cannabis for medical and recreational use.

What Are the Key Risks for GTBIF?

Insider selling — insiders were net sellers of roughly $5.1M recently.

• Regulatory uncertainty and changes in cannabis laws.
• Increased competition from other cannabis operators.
• Fluctuations in cannabis prices.
• Changes in consumer preferences.
• Limited access to capital due to federal prohibition.

What Are the Growth Opportunities for GTBIF?

• Expansion into New States: As more states legalize cannabis for medical and recreational use, Green Thumb Industries has the opportunity to expand its operations into new markets. Each new state represents a potential market of millions of consumers, driving revenue growth and increasing brand awareness. The timeline for expansion depends on the regulatory environment in each state, but GTBIF's experience in navigating complex regulatory frameworks gives it a competitive advantage.
• Increased Retail Footprint: Green Thumb Industries can continue to grow by expanding its retail footprint through new store openings and acquisitions. Each new store increases the company's direct-to-consumer sales and provides a platform for promoting its branded products. The company can strategically target locations with high foot traffic and favorable demographics to maximize sales and profitability. This expansion is ongoing, with new stores planned for 2026 and beyond.
• Product Innovation: Green Thumb Industries can drive growth by developing and launching new cannabis products that cater to evolving consumer preferences. This includes new strains of cannabis flower, innovative edibles, and advanced vaping technologies. By staying ahead of the curve and offering unique and high-quality products, GTBIF can attract new customers and increase sales among existing customers. The timeline for product innovation is continuous, with new products launched regularly.
• Strategic Acquisitions: Green Thumb Industries can pursue strategic acquisitions to expand its market share, acquire new technologies, and enter new markets. Acquisitions can provide access to valuable assets, such as cultivation facilities, processing facilities, and retail licenses. By carefully selecting acquisition targets, GTBIF can accelerate its growth and strengthen its competitive position. The timing of acquisitions is opportunistic, depending on market conditions and available opportunities.
• Increased Brand Awareness: Green Thumb Industries can invest in marketing and advertising to increase brand awareness and build customer loyalty. This includes digital marketing, social media campaigns, and partnerships with influencers. By effectively communicating its brand values and product benefits, GTBIF can attract new customers and differentiate itself from competitors. The timeline for brand awareness initiatives is ongoing, with continuous investment in marketing and advertising.

What Are GTBIF's Competitive Advantages?

• Vertically integrated operations provide control over the supply chain and product quality.
• Strong brand portfolio with established brand recognition.
• Extensive retail network provides direct access to consumers.
• Licenses to operate in key cannabis markets create barriers to entry.

What Does GTBIF Do?

Green Thumb Industries Inc. (GTBIF) was founded in 2014 and is headquartered in Chicago, Illinois. The company operates as a cannabis consumer packaged goods company, manufacturing and distributing a diverse range of cannabis products for both medical and adult-use markets in the United States. GTBIF's product portfolio includes cannabis flower, pre-rolls, concentrates, vapes, tinctures, edibles, topicals, and other cannabis-related products, marketed under brands such as Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM. The company distributes its products through third-party retail stores and directly to consumers through its own network of retail stores. As of April 11, 2022, Green Thumb Industries owned and operated 77 retail stores across the United States. GTBIF's vertically integrated business model allows it to control the entire value chain, from cultivation and processing to retail distribution, ensuring product quality and consistency. The company focuses on building strong brand recognition and customer loyalty through its diverse product offerings and retail experiences.

What Products and Services Does GTBIF Offer?

• Cultivates cannabis plants.
• Manufactures cannabis products, including flower, pre-rolls, concentrates, and edibles.
• Distributes cannabis products to third-party retail stores.
• Operates its own retail stores to sell directly to consumers.
• Develops and markets branded cannabis products under names like Beboe, Dogwalkers, and RHYTHM.
• Focuses on both medical and adult-use cannabis markets.

How Does GTBIF Make Money?

• Vertically integrated operations, from cultivation to retail.
• Generates revenue through wholesale distribution to third-party retailers.
• Direct-to-consumer sales through company-owned retail stores.
• Focus on branded cannabis products with premium pricing.

What Industry Does GTBIF Operate In?

Green Thumb Industries operates in the rapidly growing cannabis industry, driven by increasing legalization and acceptance of cannabis for medical and recreational use. The competitive landscape includes other major cannabis operators such as ARSUF (Ayr Wellness Inc.), CHIZF (Columbia Care Inc.), GENSF (Cresco Labs Inc.), GRRMF (Curaleaf Holdings Inc.), and KSPHF (Trulieve Cannabis Corp.). GTBIF's vertically integrated model and focus on branded products differentiate it within this competitive market.

Who Are GTBIF's Key Customers?

• Medical cannabis patients seeking therapeutic relief.
• Adult-use cannabis consumers seeking recreational experiences.
• Third-party retail stores that sell cannabis products.
• Wholesale distributors of cannabis products.

The most recent 12 insider filings for Green Thumb Industries Inc. break down as 4 sales and 8 purchases. On net that is roughly 19K shares acquired (about $5.1M) — insiders putting money in tends to read as conviction.

Green Thumb Industries Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 376.9% above estimates on average.

Green Thumb Industries Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.13 places it in the grey zone, a middle ground that warrants monitoring.

Return on equity for Green Thumb Industries Inc. stands at 6.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.3%, showing how much profit it generates from its asset base. GTBIF trades at a trailing price-to-earnings ratio of 13.58, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 12.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.47 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.7%, the inverse of the P/E and a quick read on earnings relative to price.

Green Thumb Industries Inc. (GTBIF) Valuation Context

Valued at $1.64B, GTBIF is classified as a small-cap stock. Analyst price targets span from $18.00 to $18.00, with a consensus of $18.00. At the current price of $7.49, that implies approximately 140% upside potential. Relative to its peer group, GTBIF's quantitative score of 57/100 is roughly in line with the peer average of 66/100.

GTBIF Revenue & Earnings Trend

In Q2 FY2026, GTBIF generated $306.7M in top-line revenue, marking a sequential increase of 2.2%. The company recorded net income of $4.9M, with diluted EPS of $0.02. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, GTBIF averaged $0.14 in diluted EPS.

Company Profile

Green Thumb Industries Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Chicago, US. The company is led by CEO Benjamin Kovler. GTBIF has traded publicly since 2018.

GTBIF Financials

GTBIF Latest News

GTBIF Analyst Consensus

GTBIF MoonshotScore

Common Questions About GTBIF (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources